Migraine Research Foundation Announces 2012 Grants
The Migraine Research Foundation, a nonprofit devoted to funding ground-breaking research into the causes and better treatments of migraine disease, today announced its 2012 grant awards. The five grants were selected from 42 proposals submitted from around the world.
New York, NY (PRWEB) January 09, 2013
The Migraine Research Foundation (MRF), a nonprofit devoted to funding ground-breaking research into the causes and better treatments of migraine disease, today announced its 2012 grant awards. The five grants were selected from 42 proposals submitted from around the world.
This year´s grantees will explore innovative inquiries in the areas of chronic migraine treatment, epidemiology, and basic science. “We are thrilled with the caliber of these projects. They all represent novel approaches to unraveling the mysteries of migraine in different ways,” said Cathy Glaser, President of MRF. “MRF has a tradition of awarding grants to some of the most promising investigators — and we know they´re going to make a difference in the lives of millions of migraine sufferers.” This year, one of the grants has been funded in its entirety by a generous donor and will be known as The Werber Family Grant.
Migraine affects 36 million Americans — 1 in 4 families, including 10% of all school-age children. And 14 million experience headaches on a near-daily basis. U.S. employers lose about $13 billion a year from lost work days. Despite being one of the world´s most disabling diseases with devastating social and economic consequences, migraine remains misunderstood, and research is woefully underfunded.
The MRF grant recipients and their projects are:
K. C. Brennan, MD and Dan Kaufmann, PhD, University of Utah, Salt Lake City, UT
Sex, Stress, and Migraine
Larus S. Gudmundsson, PhD – The Werber Family Grant, Uniformed Services University, Bethesda, MD/University of Iceland, Reykjavik, Iceland
Psychological Stressors and Their Association with the Life-course of Migraine and its Comorbidity — a Longitudinal Study
Paul Rolan, MD, School of Medical Sciences, University of Adelaide, Australia
Targeting Glial Inhibition to Attenuate Chronic Migraine: an International Double-blind Randomized, Placebo-controlled Trial of Ibudilast
Patric Stanton, PhD, NY Medical College, Valhalla, NY
N-Methyl-D-Aspartate Receptor Glycine Coagonist Site Modulation as a Potential Treatment for Migraine in Adolescent and Adult Females
Tony L. Yaksh, PhD, UCSD Medical Center, University of CA, San Diego
Role of TLR 4 and Glial Cells in Histamine and GTN Induced Migraine Mechanisms
“This year´s recipients continue to demonstrate the highly innovative thinking MRF encourages. The medical and patient communities are grateful to the Foundation and the investigators it supports,” said Dr. Joel Saper, founder of the Michigan Headache & Neurological Institute, Ann Arbor, MI, and Chair of MRF´s Medical Advisory Board.
In addition to Dr. Saper, MRF´s Medical Advisory Board of distinguished scientists and clinicians includes Sheena Aurora, MD, Stanford University, CA; Rami Burstein, PhD, Harvard University, Boston, MA; Andrew Charles, MD, David Geffen School of Medicine at UCLA; F. Michael Cutrer, MD, Mayo Clinic, Rochester, MN; Fred Freitag, DO, Baylor University Medical Center, Dallas, TX; Peter J. Goadsby, MD, PhD, DSc, University of California at San Francisco; Andrew Hershey, MD, PhD, Cincinnati Children´s Hospital Medical Center; Richard B. Lipton, MD, Albert Einstein College of Medicine, Bronx, NY; Todd Schwedt, MD, Mayo Clinic, Phoenix, AZ; Gretchen Tietjen, MD, University of Toledo; Linda Watkins, PhD, University of Colorado at Boulder; David W. Dodick, MD, Mayo Clinic, Phoenix, AZ (Emeritus); and Stephen D. Silberstein, MD, Jefferson University Headache Center, Philadelphia, PA (Emeritus).
About the Migraine Research Foundation
The Migraine Research Foundation is a nonprofit 501(c)(3) organization dedicated to ending the debilitating pain of migraine by assisting sufferers and funding research into its causes and better treatment options. Information about MRF and how to contribute can be found at http://www.migraineresearchfoundation.org.
For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2013/1/prweb10299762.htm